bluebird bio, Inc. (0HOH.L)

USD 9.28

(33.91%)

Inventory Summary of bluebird bio, Inc.

  • bluebird bio, Inc.'s latest annual inventory in 2023 was 22.91 Million USD , up 1720.86% from previous year.
  • bluebird bio, Inc.'s latest quarterly inventory in 2024 Q1 was 30.3 Million USD , up 32.23% from previous quarter.
  • bluebird bio, Inc. reported annual inventory of -1.41 Million USD in 2022, up 98.7% from previous year.
  • bluebird bio, Inc. reported annual inventory of -108.5 Million USD in 2021, up 27.52% from previous year.
  • bluebird bio, Inc. reported quarterly inventory of 33.33 Million USD for 2024 Q2, up 9.98% from previous quarter.
  • bluebird bio, Inc. reported quarterly inventory of 22.91 Million USD for 2023 Q4, up 9.3% from previous quarter.

Annual Inventory Chart of bluebird bio, Inc. (2023 - 2011)

Historical Annual Inventory of bluebird bio, Inc. (2023 - 2011)

Year Inventory Inventory Growth
2023 22.91 Million USD 1720.86%
2022 -1.41 Million USD 98.7%
2021 -108.5 Million USD 27.52%
2020 -149.7 Million USD -3.72%
2019 -144.33 Million USD 71.48%
2018 -506.12 Million USD -4305.28%
2017 -11.48 Million USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Inventory Comparison of bluebird bio, Inc.

Name Inventory Inventory Difference
Editas Medicine, Inc. - USD -Infinity%
Dynavax Technologies Corporation 53.29 Million USD 56.992%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 70.392%
Perrigo Company plc 1.14 Billion USD 97.991%
Illumina, Inc. 587 Million USD 96.096%
Thermo Fisher Scientific Inc. 5.08 Billion USD 99.55%
Iovance Biotherapeutics, Inc. 10.37 Million USD -120.97%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 99.725%
IQVIA Holdings Inc. - USD -Infinity%
Heron Therapeutics, Inc. 42.11 Million USD 45.573%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 99.112%
Unity Biotechnology, Inc. - USD -Infinity%
Waters Corporation 516.23 Million USD 95.56%
Biogen Inc. 2.52 Billion USD 99.093%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD -108.392%
Adicet Bio, Inc. - USD -Infinity%
Cara Therapeutics, Inc. 2.82 Million USD -712.442%
Esperion Therapeutics, Inc. 65.62 Million USD 65.075%
FibroGen, Inc. 41.56 Million USD 44.86%
Agilent Technologies, Inc. 1.03 Billion USD 97.777%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 74.29%
Amicus Therapeutics, Inc. 59.69 Million USD 61.607%
Myriad Genetics, Inc. 20.1 Million USD -14.025%
Viking Therapeutics, Inc. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 99.106%
Abeona Therapeutics Inc. -2.44 Million USD 1037.766%
Mettler-Toledo International Inc. 385.86 Million USD 94.06%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 97.93%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 96.898%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD 19.37%
Atara Biotherapeutics, Inc. 9.7 Million USD -136.132%
Verastem, Inc. - USD -Infinity%
Nektar Therapeutics 16.1 Million USD -42.345%
Axsome Therapeutics, Inc. 15.13 Million USD -51.43%
Aclaris Therapeutics, Inc. - USD -Infinity%
Sarepta Therapeutics, Inc. 322.85 Million USD 92.901%
OPKO Health, Inc. 65.69 Million USD 65.114%
Exelixis, Inc. 17.32 Million USD -32.304%
Neurocrine Biosciences, Inc. 38.3 Million USD 40.159%
Corcept Therapeutics Incorporated 7.73 Million USD -196.494%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 12.02 Million USD -90.61%
Imunon, Inc. - USD -Infinity%
Blueprint Medicines Corporation 21.22 Million USD -7.991%
Insmed Incorporated 83.24 Million USD 72.469%
Halozyme Therapeutics, Inc. 127.6 Million USD 82.039%
Agios Pharmaceuticals, Inc. 19.07 Million USD -20.146%
TG Therapeutics, Inc. 39.82 Million USD 42.448%
Incyte Corporation 62.97 Million USD 63.604%
Emergent BioSolutions Inc. 328.9 Million USD 93.032%